A new generation Mpro inhibitor with potent activity against SARS-CoV-2 Omicron variantsChong Huang, Shengyong Yang, Rui Zeng et al.|Signal Transduction and Targeted Therapy|2023Cited by 82
YL1004 is a SARS-CoV-2 papain-like protease inhibitor with immunomodulatory and antiviral activity in miceJinshan Nan, Shengyong Yang, Huiping Shuai et al.|Nature Communications|2026Cited by 0